Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Soft Tissue Sarcoma
Your soft tissues connect, support, or surround other tissues. Examples include your muscles, tendons, fat, and blood vessels. Soft tissue sarcoma is a cancer of these soft tissues. There are many kinds, based on the type of tissue they started in. They may cause a lump or swelling in the soft tissue. Sometimes they spread and can press on nerves and organs, causing problems such as pain or trouble breathing.
No one knows exactly what causes these cancers. They are not common, but you have a higher risk if you have been exposed to certain chemicals, have had radiation therapy, or have certain genetic diseases.
Doctors diagnose soft tissue sarcomas with a biopsy. Treatments include surgery to remove the tumor, radiation therapy, chemotherapy, or a combination.
It sits within Cancers.
The lead U.S. institute for this subject is the National Cancer Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Soft Tissue Sarcoma
3,026 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaChildren's Oncology Group
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaH. Lee Moffitt Cancer Center and Research Institute
- A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic TherapyM.D. Anderson Cancer Center
- A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)Children's Oncology Group
- Novel Biochemical and Molecular Determinants for Soft Tissue SarcomaMemorial Sloan Kettering Cancer Center
- Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial CancerNational Cancer Institute (NCI)
Research already completed
- NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid TumorsNational Cancer Institute (NCI)
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- General Information about Adult Soft Tissue SarcomaNational Cancer Institute
- Soft Tissue SarcomaMayo Foundation for Medical Education and Research
- Soft Tissue SarcomasAmerican Cancer Society
Diagnosis and Tests
- Early Detection, Diagnosis, and Staging of RhabdomyosarcomaAmerican Cancer Society
- Early Detection, Diagnosis, and Staging of Soft Tissue SarcomasAmerican Cancer Society
- Stages of Childhood RhabdomyosarcomaNational Cancer Institute
- Stages of Soft Tissue SarcomaNational Cancer Institute
- Tests for RhabdomyosarcomaAmerican Cancer Society
- Tests for Soft Tissue SarcomasAmerican Cancer Society
Treatments and Therapies
- Chemotherapy for Soft Tissue SarcomasAmerican Cancer Society
- Drugs Approved for RhabdomyosarcomaNational Cancer Institute
- Drugs Approved for Soft Tissue SarcomaNational Cancer Institute
- Radiation Therapy for Soft Tissue SarcomasAmerican Cancer Society
- Surgery for Soft Tissue SarcomasAmerican Cancer Society
Prevention and Risk Factors
- Causes, Risk Factors and Prevention of Soft Tissue SarcomasAmerican Cancer Society
Living With
- After Treatment for Soft Tissue SarcomaAmerican Cancer Society
Related Issues
- Soft Tissue Sarcomas and Agent OrangeDepartment of Veterans Affairs
Genetics
- Dermatofibrosarcoma protuberans: MedlinePlus GeneticsNational Library of Medicine
- Ewing sarcoma: MedlinePlus GeneticsNational Library of Medicine
- Li-Fraumeni syndrome: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Key Statistics for Soft Tissue SarcomasAmerican Cancer Society
- Survival Rates for Soft Tissue SarcomaAmerican Cancer Society
Clinical Trials
- ClinicalTrials.gov: RhabdomyosarcomaNational Institutes of Health
- ClinicalTrials.gov: SarcomaNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Sarcoma. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Soft Tissue Sarcoma, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.